PVMCV

Polaris Venture Management Co V Portfolio holdings

AUM $14.1M
This Quarter Return
-8.78%
1 Year Return
+121.41%
3 Year Return
+278.88%
5 Year Return
+1,121.38%
10 Year Return
AUM
$105M
AUM Growth
+$105M
Cap. Flow
+$0
Cap. Flow %
0%
Top 10 Hldgs %
100%
Holding
9
New
Increased
Reduced
Closed

Top Buys

No buys this quarter

Top Sells

No sells this quarter

Sector Composition

1 Healthcare 76.74%
Name Market Value Portfolio Weight Shares or Principal Shares
Change %
Capital Flow
TRVN
1
DELISTED
Trevena, Inc.
TRVN
$22.1M 21.09%
2,669,280
TTOO
2
DELISTED
T2 Biosystems, Inc
TTOO
$19.9M 19.01%
2,018,450
GNCA
3
DELISTED
Genocea Biosciences, Inc.
GNCA
$15.2M 14.56%
1,968,606
OCUL icon
4
Ocular Therapeutix
OCUL
$2.12B
$11.9M 11.35%
1,230,009
PULM icon
5
Pulmatrix
PULM
$18M
$10.6M 10.1%
3,607,996
DARE icon
6
Dare Bioscience
DARE
$27.2M
$8.91M 8.51%
3,287,529
ATYR
7
aTyr Pharma
ATYR
$527M
$7.2M 6.88%
1,827,992
FATE icon
8
Fate Therapeutics
FATE
$120M
$4.45M 4.25%
2,473,186
BIND
9
DELISTED
BIND THERAPEUTICS INC
BIND
$4.44M 4.24%
2,018,253